Description
Active surveillance in prostate cancer
Article: Active surveillance in prostate cancer
€2.42
Related products
-
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart -
Article: Highlights in digestive oncology
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart
